Methylated trivalent arsenic such as MMAIII and DMAIII can reduce glucose-stimulated insulin secretion (GSIS) by impairing calcium influx stimulated by glucose, thereby playing a significant role in diabetes (74). Here, INS is linked to diabetes mellitus.